UBS raised the firm’s price target on Gevo (GEVO) to $2.25 from $1.15 and keeps a Neutral rating on the shares. There is still a lack of clarity on the DOE loan conditional commitment, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEVO:
- Gevo Unveils Strategic Initiatives in Investor Presentation
- Gevo Inc’s Earnings Call Highlights Positive Financial Strides
- Take-Two, Gevo, General Dynamics, EA, eBay: Insider Sell-Offs Shake Market
- Intel CEO meets with Trump, Cardinal Health to acquire Solaris: Morning Buzz
- Gevo’s Strong Operational Performance and Strategic Positioning Drive Buy Rating